Riskpilot← Back to searchSign inGet full accessREVAC ApS
APSBankruptCVR 34628033Bag Stadion 10Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20121 employees
Revenue 2023
DKK -50K
-49% vs 2022
EBITDA margin
100.0%
+49% vs 2022
Equity ratio
-426.4%
Financial strength
Net profit 2023
DKK -313K
+11% vs 2022
| Revenue | DKK -50K | -49% |
| EBITDA | DKK -50K | +49% |
| Net profit | DKK -313K | +11% |
| Total assets | DKK 628K | -23% |
| Equity | DKK -2,7M | -13% |
| Employees | 1 | — |
Legal name
REVAC ApS
CVR number
34628033
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. august 2012
Share capital
DKK 228.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at udvikle og producere løfte- og gribemekanismer/maskiner til løft og genoptræning af personer samt dermed beslægtede aktiviteter efter bestyrelsens skøn
Address
Bag Stadion 10
Phone
+4588423566
Email
henrik@revac.dk
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 625 | 656 | 398 | -671 | -267 | -76 | -110 | -41 | -70 | -98 | -50 |
| Staff expenses | -873 | -840 | -697 | -489 | -8 | -60 | -57 | -10 | -5 | -0 | -0 |
| EBITDA | -248 | -184 | -299 | -1.161 | -275 | -136 | -167 | -51 | -65 | -98 | -50 |
| Depreciation & amort. | -0 | -0 | -0 | -992 | -992 | -992 | -3.945 | -2.000 | -0 | -200 | -200 |
| EBIT | -248 | -184 | -299 | -2.153 | -1.267 | -1.128 | -4.112 | -2.051 | -65 | -298 | -250 |
| Net financials | -3 | -78 | -157 | -261 | -266 | -296 | -328 | 2.279 | -1 | -53 | -63 |
| Profit before tax | -251 | -262 | -457 | -2.414 | -1.532 | -1.424 | -4.440 | 228 | -66 | -351 | -313 |
| Tax | -183 | -121 | -160 | -453 | -406 | -313 | -566 | -0 | -0 | -0 | -0 |
| Net profit | -67 | -140 | -297 | -1.962 | -1.127 | -1.111 | -3.875 | 228 | -66 | -351 | -313 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6.383 | 10.077 | 11.343 | 9.154 | 8.052 | 7.034 | 3.095 | 1.007 | 1.003 | 815 | 628 |
| Equity | 4.933 | 6.192 | 5.896 | 3.934 | 2.807 | 1.697 | -2.178 | -1.950 | -2.012 | -2.363 | -2.676 |
| Long-term debt | 0 | 1.481 | 2.151 | 3.810 | 4.329 | 4.737 | 5.226 | 2.911 | 2.973 | 3.135 | 3.260 |
| Short-term debt | 490 | 884 | 1.536 | 126 | 37 | 35 | 47 | 46 | 42 | 43 | 44 |
| Total debt | 490 | 2.365 | 3.687 | 3.935 | 4.366 | 4.772 | 5.273 | 2.956 | 3.015 | 3.178 | 3.304 |
EBITDA margin
-5007400.0%
This company
15.8%
Market median
-31692505% vs market
20132023
Equity ratio
-426.4%
This company
38.2%
Market median
-1216% vs market
20132023
Return on equity
-31298800.0%
This company
18.4%
Market median
-170102274% vs market
20132023
Net profit margin
-31298800.0%
This company
8.1%
Market median
-386405038% vs market
20132023
Asset turnover
-0.08×
This company
1.12×
Market median
-107% vs market
20132023
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
20132023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2012-08-10 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HH Founder | Founder | 2012 | — | — |
CT Unofficial title | Unofficial title | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2014 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
HJORT-REHAB ApS | Company | 100.0% | 100.0% | 2020 |
FONDEN SPRING NORDIC | Company | 10.0% | 0.0% | 2014 |
CAPNOVA A/S | Company | 10.0% | 25.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HHOLDING ApS
REVAC ApS Board members of REVAC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Hjort | Founder | 0 companies |
| Christian Tornvig Jensen | Unofficial title | 0 companies |
| Tom Weidner | Chairman | 0 companies |
| Lars Hallgreen | Chairman | 0 companies |
| Mogens Ivan Hjort | Board of Directors | 0 companies |